Emily Carbone

1.2k total citations
16 papers, 329 citations indexed

About

Emily Carbone is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology. According to data from OpenAlex, Emily Carbone has authored 16 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 8 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Emily Carbone's work include Prostate Cancer Treatment and Research (11 papers), Cancer Genomics and Diagnostics (6 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Emily Carbone is often cited by papers focused on Prostate Cancer Treatment and Research (11 papers), Cancer Genomics and Diagnostics (6 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Emily Carbone collaborates with scholars based in United States, United Kingdom and Italy. Emily Carbone's co-authors include Howard I. Scher, Ethan Barnett, Melanie Hullings, Ryan Dittamore, Ryon P. Graf, Andreas G. Wibmer, Nikolaus Schultz, Konrad H. Stopsack, Michael J. Morris and Wassim Abida and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Emily Carbone

15 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emily Carbone United States 9 218 156 124 98 36 16 329
Angelina T. Regua United States 10 97 0.4× 84 0.5× 195 1.6× 184 1.9× 35 1.0× 14 364
Di Gu China 11 189 0.9× 117 0.8× 83 0.7× 201 2.1× 17 0.5× 37 399
Anne Cathrine Bakken Norway 12 173 0.8× 156 1.0× 50 0.4× 182 1.9× 19 0.5× 17 364
Liguo Ye China 13 124 0.6× 114 0.7× 54 0.4× 141 1.4× 16 0.4× 27 331
Shazia Irshad United Kingdom 9 124 0.6× 110 0.7× 100 0.8× 209 2.1× 9 0.3× 12 356
Hubert Pakula United States 11 166 0.8× 142 0.9× 100 0.8× 242 2.5× 8 0.2× 17 415
Raviprakash T. Sitaram Sweden 9 106 0.5× 83 0.5× 65 0.5× 179 1.8× 51 1.4× 13 315
Aian Neil Alilin United States 4 109 0.5× 95 0.6× 137 1.1× 141 1.4× 13 0.4× 8 293
Lisa Blaydorn United States 6 68 0.3× 59 0.4× 290 2.3× 78 0.8× 21 0.6× 8 386
Jiawei Cao China 11 71 0.3× 81 0.5× 88 0.7× 157 1.6× 40 1.1× 20 267

Countries citing papers authored by Emily Carbone

Since Specialization
Citations

This map shows the geographic impact of Emily Carbone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Carbone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Carbone more than expected).

Fields of papers citing papers by Emily Carbone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Carbone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Carbone. The network helps show where Emily Carbone may publish in the future.

Co-authorship network of co-authors of Emily Carbone

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Carbone. A scholar is included among the top collaborators of Emily Carbone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Carbone. Emily Carbone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Barnett, Ethan, Nikolaus Schultz, Konrad H. Stopsack, et al.. (2022). Analysis of BRCA2 Copy Number Loss and Genomic Instability in Circulating Tumor Cells from Patients with Metastatic Castration-resistant Prostate Cancer. European Urology. 83(2). 112–120. 10 indexed citations
2.
Keegan, Niamh M., Ethan Barnett, Emily Carbone, et al.. (2022). Clinical annotations for prostate cancer research: Defining data elements, creating a reproducible analytical pipeline, and assessing data quality. The Prostate. 82(11). 1107–1116. 4 indexed citations
3.
Barnett, Ethan, et al.. (2022). Genomic alterations and evolution in patients with prostate cancer with histologic evidence of neuroendocrine differentiation.. Journal of Clinical Oncology. 40(16_suppl). 5029–5029. 1 indexed citations
4.
Scher, Howard I., Andrew J. Armstrong, Joseph D. Schonhoft, et al.. (2021). Development and validation of circulating tumour cell enumeration (Epic Sciences) as a prognostic biomarker in men with metastatic castration-resistant prostate cancer. European Journal of Cancer. 150. 83–94. 31 indexed citations
5.
Scher, Howard I., Katherine Cunningham, Ethan Barnett, et al.. (2021). Schlafen 11 (SLFN11), a putative predictive biomarker of platinum/PARPi response, is frequently detected on circulating tumor cells (CTCs) in advanced prostate cancer.. Journal of Clinical Oncology. 39(15_suppl). e17039–e17039. 3 indexed citations
6.
Stopsack, Konrad H., Subhiksha Nandakumar, Andreas G. Wibmer, et al.. (2020). Oncogenic Genomic Alterations, Clinical Phenotypes, and Outcomes in Metastatic Castration-Sensitive Prostate Cancer. Clinical Cancer Research. 26(13). 3230–3238. 119 indexed citations
7.
Lu, David, Rachel Krupa, Melissa Harvey, et al.. (2020). Development of an immunofluorescent AR-V7 circulating tumor cell assay – A blood-based test for men with metastatic prostate cancer. SHILAP Revista de lepidopterología. 9(1). 13–19. 8 indexed citations
8.
Schonhoft, Joseph D., Jimmy L. Zhao, Adam Jendrisak, et al.. (2020). Morphology-Predicted Large-Scale Transition Number in Circulating Tumor Cells Identifies a Chromosomal Instability Biomarker Associated with Poor Outcome in Castration-Resistant Prostate Cancer. Cancer Research. 80(22). 4892–4903. 32 indexed citations
10.
Graf, Ryon P., Melanie Hullings, Ethan Barnett, et al.. (2019). Clinical Utility of the Nuclear-localized AR-V7 Biomarker in Circulating Tumor Cells in Improving Physician Treatment Choice in Castration-resistant Prostate Cancer. European Urology. 77(2). 170–177. 58 indexed citations
11.
Abida, Wassim, Michael L. Cheng, Joshua Armenia, et al.. (2018). Microsatellite instability in prostate cancer and response to immune checkpoint blockade.. Journal of Clinical Oncology. 36(15_suppl). 5020–5020. 10 indexed citations
13.
Ferro, Austin, et al.. (2017). Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function. Journal of Visualized Experiments. 4 indexed citations
15.
Ferro, Austin, et al.. (2017). Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function. Journal of Visualized Experiments. 1 indexed citations
16.
Motta, Giovanni, et al.. (2000). Considerations about tumor size as a factor of prognosis in NSCLC.. PubMed. 70(6). 893–7. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026